Immunowake - Crunchbase Company Profile & Funding

Q: Where is Immunowake's headquarters?

Immunowake is located in Birmingham, Alabama, United States.

Q: Who invested in Immunowake?

Immunowake has 4 investors including Hyfinity Investments And South China Venture Capital.

Q: When was the last funding round for Immunowake?

Immunowake closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Immunowake raised to date?

Immunowake has raised obfuscated.

Overview

Immunowake

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Immunowake

CB Rank

52034

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.

Founded

obfuscation

Private

Series A

Birmingham, Alabama, United States

11-50

www.immunowake.com/

Biotechnology

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Ellen Wu: Co-founder
Xiaoyun Wu: Founder

Details

Legal Name

Immunowake Inc.

Operating Status

Active

Company Type

For Profit

Founders

Ellen Wu, Xiaoyun Wu

About the Company

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies. Immunotherapy involves harnessing the body’s immune system to identify and kill cancer cells in the same way pathogens are identified and targeted. Recent breakthroughs in cancer immunotherapy have

demonstrated that powerful anti-tumor responses can be achieved by activating antigen-specific T-cells.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

VEGF Trap Platform

A bi-specific antibody platform that targets vascular endothelial growth factor (VEGF) and checkpoint inhibitors to enhance anti-tumor effects and reduce cancer angiogenesis.

CD3 Bi-Specific Platform

A bi-specific antibody platform that targets CD3 on T-cells and tumor-associated antigens to redirect T-cells for targeted cancer cell killing.

Research & Development

Immunowake is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A
obfuscated obfuscation	Series A - Immunowake	4	obfuscated obfuscation	Hyfinity Investments, South China Venture Capital	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Hyfinity Investments	Yes	Series A - Immunowake	—
Hyfinity Investments	Yes	Series A - Immunowake	—
Hyfinity Investments	Yes	Series A - Immunowake	—
Hyfinity Investments	Yes	Series A - Immunowake	—
Hyfinity Investments	Yes	Series A - Immunowake	—